[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Wall St Engine @wallstengine on x 73.8K followers
Created: 2025-07-08 13:15:27 UTC
Novo Nordisk $NVO submits a new higher dose (7.2mg) of Wegovy to the EMA after trials showed XX% average weight loss, with a third of patients losing 25%+. Safety profile consistent with current 2.4mg dose. Another push by Novo Nordisk to expand its obesity treatment portfolio.
XXXXXX engagements
Related Topics weight loss ema wegovy $novcde $nvo stocks healthcare